 | • レポートコード：MRC2Q12-19042 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、糞便微生物叢移植のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 糞便微生物叢移植のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 糞便微生物叢移植の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 糞便微生物叢移植のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの糞便微生物叢移植の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の糞便微生物叢移植の売上および2028年までの予測に焦点を当てています。 糞便微生物叢移植のグローバル主要企業には、Rebiotix、Finch Therapeutics、Seres Therapeutics、Crestovoなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 糞便微生物叢移植市場は、タイプとアプリケーションによって区分されます。世界の糞便微生物叢移植市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 フェーズI、フェーズ2、フェーズ3、フェーズ4 【アプリケーション別セグメント】 クロストリジウム・ディフィシル感染症、パーキンソン病、肥満、糖尿病、自閉症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 糞便微生物叢移植製品概要 - タイプ別市場（フェーズI、フェーズ2、フェーズ3、フェーズ4） - アプリケーション別市場（クロストリジウム・ディフィシル感染症、パーキンソン病、肥満、糖尿病、自閉症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の糞便微生物叢移植販売量予測2017-2028 - 世界の糞便微生物叢移植売上予測2017-2028 - 糞便微生物叢移植の地域別販売量 - 糞便微生物叢移植の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別糞便微生物叢移植販売量 - 主要メーカー別糞便微生物叢移植売上 - 主要メーカー別糞便微生物叢移植価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（フェーズI、フェーズ2、フェーズ3、フェーズ4） - 糞便微生物叢移植のタイプ別販売量 - 糞便微生物叢移植のタイプ別売上 - 糞便微生物叢移植のタイプ別価格 ・アプリケーション別市場規模（クロストリジウム・ディフィシル感染症、パーキンソン病、肥満、糖尿病、自閉症、その他） - 糞便微生物叢移植のアプリケーション別販売量 - 糞便微生物叢移植のアプリケーション別売上 - 糞便微生物叢移植のアプリケーション別価格 ・北米市場 - 北米の糞便微生物叢移植市場規模（タイプ別、アプリケーション別） - 主要国別の糞便微生物叢移植市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの糞便微生物叢移植市場規模（タイプ別、アプリケーション別） - 主要国別の糞便微生物叢移植市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の糞便微生物叢移植市場規模（タイプ別、アプリケーション別） - 主要国別の糞便微生物叢移植市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の糞便微生物叢移植市場規模（タイプ別、アプリケーション別） - 主要国別の糞便微生物叢移植市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの糞便微生物叢移植市場規模（タイプ別、アプリケーション別） - 主要国別の糞便微生物叢移植市場規模（トルコ、サウジアラビア） ・企業情報 Rebiotix、Finch Therapeutics、Seres Therapeutics、Crestovo ・産業チェーン及び販売チャネル分析 - 糞便微生物叢移植の産業チェーン分析 - 糞便微生物叢移植の原材料 - 糞便微生物叢移植の生産プロセス - 糞便微生物叢移植の販売及びマーケティング - 糞便微生物叢移植の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 糞便微生物叢移植の産業動向 - 糞便微生物叢移植のマーケットドライバー - 糞便微生物叢移植の課題 - 糞便微生物叢移植の阻害要因 ・主な調査結果 |
Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient. This procedure restores the balance of bacteria in the digestive tract by replenishing the population of ‘good’ bacteria that is either suppressed by the overpopulation of ‘bad’ bacteria or has been killed. Prepared fecal microbiota transplantation is a thoroughly screened process. It is carried out in the lower gastrointestinal tract through colonoscopy or enema and in the upper gastrointestinal tract through the nasoduodenal or nasogastric tube. Currently, fecal microbiota transplantation is being studied for the treatment of Clostridium difficile infection but can be used for the treatment of gut dysbiosis after heavy treatment such as chemotherapy. Patietns with recurrent clostridium infections treated with fecal microbiota transplantation have shown high rates of success. A study has found that 90% recurrent C. difficile cases treated with fecal microbiota transplantation achieve clinical resolution. Thus, this has elevated fecal microbiota transplantation as an emerging treatment for a wide range of disorders, including fibromyalgia, Parkinson’s disease, myoclonus dystopia, chronic fatigue syndrome, multiple sclerosis, insulin resistance, obesity, metabolic syndrome, and autism.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Fecal Microbiota Transplantation estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Fecal Microbiota Transplantation include Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Fecal Microbiota Transplantation companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Fecal Microbiota Transplantation market. Further, it explains the major drivers and regional dynamics of the global Fecal Microbiota Transplantation market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Fecal Microbiota Transplantation Segment by Type
Phase-I
Phase-2
Phase-3
Phase-4
Fecal Microbiota Transplantation Segment by Application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fecal Microbiota Transplantation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Fecal Microbiota Transplantation market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Fecal Microbiota Transplantation, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fecal Microbiota Transplantation, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fecal Microbiota Transplantation revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Fecal Microbiota Transplantation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Fecal Microbiota Transplantation revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fecal Microbiota Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fecal Microbiota Transplantation companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fecal Microbiota Transplantation revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fecal Microbiota Transplantation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Phase-I
1.2.3 Phase-2
1.2.4 Phase-3
1.2.5 Phase-4
1.3 Market by Application
1.3.1 Global Fecal Microbiota Transplantation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clostridium Difficile Infections
1.3.3 Parkinson Disease
1.3.4 Obesity
1.3.5 Diabetes Mellitus
1.3.6 Autism
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fecal Microbiota Transplantation Market Perspective (2017-2028)
2.2 Fecal Microbiota Transplantation Growth Trends by Region
2.2.1 Fecal Microbiota Transplantation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fecal Microbiota Transplantation Historic Market Size by Region (2017-2022)
2.2.3 Fecal Microbiota Transplantation Forecasted Market Size by Region (2023-2028)
2.3 Fecal Microbiota Transplantation Market Dynamics
2.3.1 Fecal Microbiota Transplantation Industry Trends
2.3.2 Fecal Microbiota Transplantation Market Drivers
2.3.3 Fecal Microbiota Transplantation Market Challenges
2.3.4 Fecal Microbiota Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fecal Microbiota Transplantation Players by Revenue
3.1.1 Global Top Fecal Microbiota Transplantation Players by Revenue (2017-2022)
3.1.2 Global Fecal Microbiota Transplantation Revenue Market Share by Players (2017-2022)
3.2 Global Fecal Microbiota Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fecal Microbiota Transplantation Revenue
3.4 Global Fecal Microbiota Transplantation Market Concentration Ratio
3.4.1 Global Fecal Microbiota Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fecal Microbiota Transplantation Revenue in 2021
3.5 Fecal Microbiota Transplantation Key Players Head office and Area Served
3.6 Key Players Fecal Microbiota Transplantation Product Solution and Service
3.7 Date of Enter into Fecal Microbiota Transplantation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fecal Microbiota Transplantation Breakdown Data by Type
4.1 Global Fecal Microbiota Transplantation Historic Market Size by Type (2017-2022)
4.2 Global Fecal Microbiota Transplantation Forecasted Market Size by Type (2023-2028)
5 Fecal Microbiota Transplantation Breakdown Data by Application
5.1 Global Fecal Microbiota Transplantation Historic Market Size by Application (2017-2022)
5.2 Global Fecal Microbiota Transplantation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fecal Microbiota Transplantation Market Size (2017-2028)
6.2 North America Fecal Microbiota Transplantation Market Size by Type
6.2.1 North America Fecal Microbiota Transplantation Market Size by Type (2017-2022)
6.2.2 North America Fecal Microbiota Transplantation Market Size by Type (2023-2028)
6.2.3 North America Fecal Microbiota Transplantation Market Share by Type (2017-2028)
6.3 North America Fecal Microbiota Transplantation Market Size by Application
6.3.1 North America Fecal Microbiota Transplantation Market Size by Application (2017-2022)
6.3.2 North America Fecal Microbiota Transplantation Market Size by Application (2023-2028)
6.3.3 North America Fecal Microbiota Transplantation Market Share by Application (2017-2028)
6.4 North America Fecal Microbiota Transplantation Market Size by Country
6.4.1 North America Fecal Microbiota Transplantation Market Size by Country (2017-2022)
6.4.2 North America Fecal Microbiota Transplantation Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fecal Microbiota Transplantation Market Size (2017-2028)
7.2 Europe Fecal Microbiota Transplantation Market Size by Type
7.2.1 Europe Fecal Microbiota Transplantation Market Size by Type (2017-2022)
7.2.2 Europe Fecal Microbiota Transplantation Market Size by Type (2023-2028)
7.2.3 Europe Fecal Microbiota Transplantation Market Share by Type (2017-2028)
7.3 Europe Fecal Microbiota Transplantation Market Size by Application
7.3.1 Europe Fecal Microbiota Transplantation Market Size by Application (2017-2022)
7.3.2 Europe Fecal Microbiota Transplantation Market Size by Application (2023-2028)
7.3.3 Europe Fecal Microbiota Transplantation Market Share by Application (2017-2028)
7.4 Europe Fecal Microbiota Transplantation Market Size by Country
7.4.1 Europe Fecal Microbiota Transplantation Market Size by Country (2017-2022)
7.4.2 Europe Fecal Microbiota Transplantation Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fecal Microbiota Transplantation Market Size (2017-2028)
8.2 Asia-Pacific Fecal Microbiota Transplantation Market Size by Type
8.2.1 Asia-Pacific Fecal Microbiota Transplantation Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fecal Microbiota Transplantation Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fecal Microbiota Transplantation Market Share by Type (2017-2028)
8.3 Asia-Pacific Fecal Microbiota Transplantation Market Size by Application
8.3.1 Asia-Pacific Fecal Microbiota Transplantation Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fecal Microbiota Transplantation Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fecal Microbiota Transplantation Market Share by Application (2017-2028)
8.4 Asia-Pacific Fecal Microbiota Transplantation Market Size by Region
8.4.1 Asia-Pacific Fecal Microbiota Transplantation Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fecal Microbiota Transplantation Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fecal Microbiota Transplantation Market Size (2017-2028)
9.2 Latin America Fecal Microbiota Transplantation Market Size by Type
9.2.1 Latin America Fecal Microbiota Transplantation Market Size by Type (2017-2022)
9.2.2 Latin America Fecal Microbiota Transplantation Market Size by Type (2023-2028)
9.2.3 Latin America Fecal Microbiota Transplantation Market Share by Type (2017-2028)
9.3 Latin America Fecal Microbiota Transplantation Market Size by Application
9.3.1 Latin America Fecal Microbiota Transplantation Market Size by Application (2017-2022)
9.3.2 Latin America Fecal Microbiota Transplantation Market Size by Application (2023-2028)
9.3.3 Latin America Fecal Microbiota Transplantation Market Share by Application (2017-2028)
9.4 Latin America Fecal Microbiota Transplantation Market Size by Country
9.4.1 Latin America Fecal Microbiota Transplantation Market Size by Country (2017-2022)
9.4.2 Latin America Fecal Microbiota Transplantation Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fecal Microbiota Transplantation Market Size (2017-2028)
10.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Type
10.2.1 Middle East & Africa Fecal Microbiota Transplantation Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fecal Microbiota Transplantation Market Share by Type (2017-2028)
10.3 Middle East & Africa Fecal Microbiota Transplantation Market Size by Application
10.3.1 Middle East & Africa Fecal Microbiota Transplantation Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fecal Microbiota Transplantation Market Share by Application (2017-2028)
10.4 Middle East & Africa Fecal Microbiota Transplantation Market Size by Country
10.4.1 Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Rebiotix
11.1.1 Rebiotix Company Details
11.1.2 Rebiotix Business Overview
11.1.3 Rebiotix Fecal Microbiota Transplantation Introduction
11.1.4 Rebiotix Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.1.5 Rebiotix Recent Developments
11.2 Finch Therapeutics
11.2.1 Finch Therapeutics Company Details
11.2.2 Finch Therapeutics Business Overview
11.2.3 Finch Therapeutics Fecal Microbiota Transplantation Introduction
11.2.4 Finch Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.2.5 Finch Therapeutics Recent Developments
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Details
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Fecal Microbiota Transplantation Introduction
11.3.4 Seres Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.3.5 Seres Therapeutics Recent Developments
11.4 Crestovo
11.4.1 Crestovo Company Details
11.4.2 Crestovo Business Overview
11.4.3 Crestovo Fecal Microbiota Transplantation Introduction
11.4.4 Crestovo Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.4.5 Crestovo Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer